Published in Cancer Epidemiol Biomarkers Prev on September 18, 2013
The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95
A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol (2007) 2.80
Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev (2002) 2.42
Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst (2001) 2.13
Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics (1999) 1.77
Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer (1997) 1.69
Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst (2001) 1.68
Variability of serum prolactin and progesterone levels in normal women: the relevance of single hormone measurements in the clinical setting. Obstet Gynecol (1990) 1.55
Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts. J Clin Oncol (2001) 1.48
Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol (1992) 1.48
Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res (1980) 1.46
Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat (1990) 1.45
Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst (1983) 1.44
Prolactin and breast cancer etiology: an epidemiologic perspective. J Mammary Gland Biol Neoplasia (2008) 1.42
Exioliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast. Cancer (1958) 1.28
Cytologic evaluation of breast fluid in the detection of breast disease. J Natl Cancer Inst (1977) 1.24
New mechanisms for PRLr action in breast cancer. Trends Endocrinol Metab (2009) 1.08
Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS. Int J Cancer (2005) 1.06
Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.01
Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins. Cancer Epidemiol Biomarkers Prev (2006) 0.94
Associations of body size and reproductive factors with circulating levels of sex hormones and prolactin in premenopausal Japanese women. Cancer Causes Control (2011) 0.91
Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland. Breast Cancer Res (2011) 0.83
Serum prolactin in breastfeeding: state of the science. Biol Res Nurs (1999) 0.79
Cellular and hormonal content of breast nipple aspirate fluid in relation to the risk of breast cancer. Biomark Med (2008) 0.78
Prolactin levels and examination with breast ultrasound or mammography. Adv Ther (2008) 0.78
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst (2002) 9.45
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin (2012) 4.32
NFKBIA deletion in glioblastomas. N Engl J Med (2010) 3.96
Prostate specific antigen best practice statement: 2009 update. J Urol (2009) 3.95
A meta-analysis of human acellular dermis and submuscular tissue expander breast reconstruction. Plast Reconstr Surg (2012) 3.30
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
A network model of a cooperative genetic landscape in brain tumors. JAMA (2009) 2.86
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw (2009) 2.78
What is the true number needed to screen and treat to save a life with prostate-specific antigen testing? J Clin Oncol (2010) 2.49
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol (2014) 2.38
Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg (2013) 2.37
Role of diet in prostate cancer development and progression. J Clin Oncol (2005) 2.29
Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab (2007) 2.29
Randomized trials of antioxidant supplementation for cancer prevention: first bias, now chance--next, cause. JAMA (2008) 2.24
Autologous options for postmastectomy breast reconstruction: a comparison of outcomes based on the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg (2012) 2.20
Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev (2010) 2.09
What are safe margins of resection for invasive and in situ breast cancer? Oncology (Williston Park) (2011) 2.08
Evidence for field cancerization of the prostate. Prostate (2009) 1.86
Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas. JAMA (2009) 1.81
The effects of a low-fat/high-fiber diet on sex hormone levels and menstrual cycling in premenopausal women: a 12-month randomized trial (the diet and hormone study). Cancer (2003) 1.81
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet (2013) 1.78
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. Cancer Prev Res (Phila) (2012) 1.69
Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev (2002) 1.67
Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial. J Natl Cancer Inst (2007) 1.65
Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow-up. Cancer (2004) 1.59
Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res (2006) 1.58
Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer. Ann Surg (2013) 1.56
Combining biomarkers to detect disease with application to prostate cancer. Biostatistics (2003) 1.54
Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev (2002) 1.48
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
Effect of MRI on the management of ductal carcinoma in situ of the breast. Ann Surg Oncol (2012) 1.46
Surgery for the intact primary and stage IV breast cancer…lacking "robust evidence". Ann Surg Oncol (2013) 1.46
Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. Mol Endocrinol (2006) 1.39
Gene expression patterns in the human breast after pregnancy. Cancer Prev Res (Phila) (2010) 1.31
Radon and lung cancer in the American Cancer Society cohort. Cancer Epidemiol Biomarkers Prev (2011) 1.30
alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat (2007) 1.29
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol (2014) 1.28
Risk factors for prostate cancer. Rev Urol (2002) 1.21
Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter. BMC Biotechnol (2008) 1.21
The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer. Proc Natl Acad Sci U S A (2002) 1.21
mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials. Exp Mol Pathol (2009) 1.17
Comparison of milk output between mothers of preterm and term infants: the first 6 weeks after birth. J Hum Lact (2005) 1.16
Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma. Mod Pathol (2008) 1.13
Primary tumor resection in stage IV breast cancer: consistent benefit, or consistent bias? Ann Surg Oncol (2007) 1.13
Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2007) 1.11
Caffeine and risk of Parkinson's disease in a large cohort of men and women. Mov Disord (2012) 1.10
Morphological changes in breast tissue with menstrual cycle. Mod Pathol (2002) 1.08
Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer. BMC Cancer (2006) 1.08
A comparison of ductoscopy-guided and conventional surgical excision in women with spontaneous nipple discharge. Ann Surg (2005) 1.08
Concerns about methods for determination of estrogens in body fluids. Breast Cancer Res Treat (2014) 1.08
Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer. Prostate (2005) 1.07
Array-based multiplex analysis of DNA methylation in breast cancer tissues. J Mol Diagn (2007) 1.07
Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer. Cancer (2008) 1.06
Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge. Clin Cancer Res (2009) 1.05
Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. Cancer Res (2011) 1.03
Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res (2003) 1.03
Prostate specific antigen best practice statement: 2009 update. J Urol (2013) 1.03
Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection? Cancer Epidemiol Biomarkers Prev (2004) 1.02
Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in Black and White men: the CARDIA Male Hormone Study. Cancer Epidemiol Biomarkers Prev (2004) 1.01
Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.01
Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma. Lab Invest (2008) 1.01
Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.01
Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer. Am J Pathol (2008) 1.00
Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res (2005) 1.00
Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Cancer Res (2008) 0.99
Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. Cancer Res (2008) 0.99
Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. J Endocrinol (2008) 0.98
The kinetics of binding human prolactin, but not growth hormone, to the prolactin receptor vary over a physiologic pH range. Biochemistry (2007) 0.97
Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations. Cancer Epidemiol Biomarkers Prev (2010) 0.97
Childhood conditions influence adult progesterone levels. PLoS Med (2007) 0.97
Novel association of Vav2 and Nek3 modulates signaling through the human prolactin receptor. Mol Endocrinol (2004) 0.96
Association between recency of last pregnancy and biologic subtype of breast cancer. Ann Surg Oncol (2011) 0.96
Comparison of hormone levels in nipple aspirate fluid of pre- and postmenopausal women: effect of oral contraceptives and hormone replacement. J Clin Endocrinol Metab (2004) 0.95
Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women. Breast Cancer Res Treat (2007) 0.95
Effect of size, surface charge, and hydrophobicity of poly(amidoamine) dendrimers on their skin penetration. Biomacromolecules (2012) 0.94
Dietary factors and risk of t(14;18)-defined subgroups of non-Hodgkin lymphoma. Cancer Causes Control (2008) 0.94
Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells. Endocrinology (2008) 0.94
Physical inactivity and percent breast density among Hispanic women. Int J Cancer (2003) 0.94
Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins. Cancer Epidemiol Biomarkers Prev (2006) 0.94
Contralateral prophylactic mastectomy: what do we know and what do our patients know? J Clin Oncol (2011) 0.93
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression. J Clin Invest (2014) 0.93
Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: effects on circulating IGF-I and its binding proteins in premenopausal women. Int J Cancer (2005) 0.92
The chromosome 3q25 genomic region is associated with measures of adiposity in newborns in a multi-ethnic genome-wide association study. Hum Mol Genet (2013) 0.92
Effect of including cancer-specific variables on models examining short-term outcomes. Cancer (2012) 0.92
Formation of estrone and estradiol from estrone sulfate by normal breast parenchymal tissue. J Steroid Biochem Mol Biol (2003) 0.91
The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells. Exp Cell Res (2008) 0.91
Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain. Mol Endocrinol (2002) 0.90
A prospective study of variability in mammographic density during the menstrual cycle. Breast Cancer Res Treat (2009) 0.90
Estimated phytanic acid intake and prostate cancer risk: a prospective cohort study. Int J Cancer (2012) 0.89
Sex hormones and risks of rheumatoid arthritis and developmental or environmental influences. Ann N Y Acad Sci (2006) 0.88